Want to track EGTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Egetis Therapeutics AB (EGTX) Statistics
Valuation metrics
Market Cap 3.13B
Enterprise value 4.31B
Trailing P/E (ttm) -9.83
Forward P/E -
PEG ratio 11.54
Price/Sales (ttm) 69.85
Price/Book (mrq) 9.26
Enterprise Value/Revenue 65.16
Enterprise Value/EBITDA -11.35
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 4.88M
Average volume (90 days) 1.79M
Price summary
52-Week low 3.12
52-Week high 7.07
Beta -
50-Day moving average 8.2
200-Day moving average 6.64
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -6.13%
Operating margin -6.04%
Operational effectiveness
Return on assets -0.53%
Return on equity -1.2%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.15
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.9
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.84
Total debt (mrq) -
Total Debt/Equity (mrq) 0.14
Current ratio (mrq) 1.49%
Book value per share (mrq) 1.07
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
